Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases.
Raptis CE, Berger CT, Ciurea A, Andrey DO, Polysopoulos C, Lescuyer P, Maletic T, Riek M, Scherer A, von Loga I, Safford J, Lauper K, Möller B, Vuilleumier N, Finckh A, Rubbert-Roth A. Raptis CE, et al. Among authors: vuilleumier n. Front Immunol. 2022 Oct 13;13:1016927. doi: 10.3389/fimmu.2022.1016927. eCollection 2022. Front Immunol. 2022. PMID: 36311791 Free PMC article.
Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA.1/BA.2 infection.
Perez-Saez J, Zaballa ME, Lamour J, Yerly S, Dubos R, Courvoisier DS, Villers J, Balavoine JF, Pittet D, Kherad O, Vuilleumier N, Kaiser L, Guessous I, Stringhini S, Azman AS; Specchio-COVID19 study group. Perez-Saez J, et al. Among authors: vuilleumier n. Nat Commun. 2023 May 26;14(1):3032. doi: 10.1038/s41467-023-38744-7. Nat Commun. 2023. PMID: 37230973 Free PMC article.
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study.
Zaballa ME, Perez-Saez J, de Mestral C, Pullen N, Lamour J, Turelli P, Raclot C, Baysson H, Pennacchio F, Villers J, Duc J, Richard V, Dumont R, Semaani C, Loizeau AJ, Graindorge C, Lorthe E, Balavoine JF, Pittet D, Schibler M, Vuilleumier N, Chappuis F, Kherad O, Azman AS, Posfay-Barbe KM, Kaiser L, Trono D, Stringhini S, Guessous I; Specchio-COVID19 study group. Zaballa ME, et al. Among authors: vuilleumier n. Lancet Reg Health Eur. 2023 Jan;24:100547. doi: 10.1016/j.lanepe.2022.100547. Epub 2022 Dec 1. Lancet Reg Health Eur. 2023. PMID: 36474728 Free PMC article.
Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study.
Leidi A, Koegler F, Dumont R, Dubos R, Zaballa ME, Piumatti G, Coen M, Berner A, Darbellay Farhoumand P, Vetter P, Vuilleumier N, Kaiser L, Courvoisier D, Azman AS, Guessous I, Stringhini S; SEROCoV-POP study group. Leidi A, et al. Among authors: vuilleumier n. Clin Infect Dis. 2022 Mar 1;74(4):622-629. doi: 10.1093/cid/ciab495. Clin Infect Dis. 2022. PMID: 34043763 Free PMC article.
National Unified Renal Translational Research Enterprise: Idiopathic Nephrotic Syndrome (NURTuRE-INS) study.
Colby E, Hayward S, Benavente M, Robertson F, Bierzynska A, Osborne A, Parmesar K, Afzal M, Chapman T, Ullah F, Davies E, Nation M, Cook W, Johnson T, Andag U, Radresa O, Skroblin P, Bayerlova M, Unwin R, Vuilleumier N, Banks RE, Braddon F, Koziell A, Taal MW, Welsh GI, Saleem MA. Colby E, et al. Among authors: vuilleumier n. Clin Kidney J. 2024 Mar 30;17(8):sfae096. doi: 10.1093/ckj/sfae096. eCollection 2024 Aug. Clin Kidney J. 2024. PMID: 39135942 Free PMC article.
Persistent symptoms after SARS-CoV-2 infection in children: a cross-sectional population-based serological study.
Dumont R, Nehme M, Lorthe E, De Mestral C, Richard V, Baysson H, Pennacchio F, Lamour J, Semaani C, Zaballa ME, Pullen N, Perrin A, L'Huillier AG, Posfay-Barbe KM, Guessous I, Stringhini S; Specchio-COVID19 study group. Dumont R, et al. BMJ Open. 2022 Nov 21;12(11):e063504. doi: 10.1136/bmjopen-2022-063504. BMJ Open. 2022. PMID: 36410813 Free PMC article.
Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA.
Schmiedeberg K, Abela IA, Pikor NB, Vuilleumier N, Schwarzmueller M, Epp S, Pagano S, Grabherr S, Patterson AB, Nussberger M, Trkola A, Ludewig B, von Kempis J, Rubbert-Roth A. Schmiedeberg K, et al. Among authors: vuilleumier n. RMD Open. 2022 Oct;8(2):e002575. doi: 10.1136/rmdopen-2022-002575. RMD Open. 2022. PMID: 36288822 Free PMC article.
192 results